Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-151305

President & CEO sold 93,458 shares at an average $13.88 ($1,296,799)

  • President & CEO acquired 87,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2016-11-16 Sale : show line 1 in the form −5,958 $13.96 $83,174 122,908 D
2016-11-17 Exercise or conversion : show line 2 in the form +87,500 $4.65 $406,875 210,408 D
2016-11-17 Sale : show line 3 in the form −87,500 $13.87 $1,213,625 122,908 D
Open-market sales · 93,458 sh · avg $13.88 · $1,296,799

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-11-17 Exercise or conversion : show line 4 in the form Stock Option −87,500 $4.65 2017-02-22 87,500 262,500 D
Loading xslF345X03/doc4.xml…